 The novel coronavirus, NCOV, has been shown to cause oxidative stress in infected individuals, leading to decreased levels of antioxidants such as glutathione, GSH. This can lead to increased levels of reactive oxygen species, ROS, which can damage cells and tissues. N-acetylcysteine, NAC, is a precursor for the production of GSH and its administration has been shown to reduce ROS levels in other diseases. In this study, researchers investigated whether NAC could be used to treat NCOV-infected patients. They found that NAC significantly reduced oxidative stress markers in the blood of patients with NCOV infection, suggesting that it could be a potential treatment option. This article was authored by Maria Elena Soto, Linalo Manzano-Pesh, Adrian Palacios-Deveria, and others.